Skip to main content
OpenTrials

Clinical trial condition

Retinal Degeneration

Explore clinical trials studying Retinal Degeneration. Study availability and eligibility vary by location and protocol.

94 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Retinal Degeneration trial results

Completed

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

NCT06455826

Conditions
Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +4 more
Locations
  • University of Florida Health Jacksonville, Florida, United States
  • University of Michigan Kellogg Eye Center Ann Arbor, Michigan, United States
  • Oregon Health and Science University - Casey Eye Institute Portland, Oregon, United States
  • Retina Foundation of the Southwest Dallas, Texas, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

NCT06270836

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +14 more
Locations
  • Retina Associates SW Tucson, Arizona, United States
  • Retina Consultants of Orange County Fullerton, California, United States
  • Global Research Management, Inc. - Lugene Eye Institute Glendale, California, United States
  • Retinal Consultants Medical Group, Inc. Modesto, California, United States
View all 39 locations
View Trial Details
Completed

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

NCT04679935

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Regensburg, Bavaria, Germany
  • Novartis Investigative Site Frankfurt am Main, Hesse, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Bonn, Germany
View all 19 locations
View Trial Details
Completed

Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

NCT05697809

Conditions
Diabetic Macular Edema, Edema, Eye Diseases, +7 more
Locations
  • Retinal Research Institute, LLC Phoenix, Arizona, United States
  • Blue Ocean Clinical Research West Clearwater, Florida, United States
  • University Retina and Macula Associates Oak Forest, Illinois, United States
  • Retina Consultants of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

NCT06011798

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +18 more
Locations
  • California Retina Consultants Bakersfield, California, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Salehi Retina Institute Inc. Huntington Beach, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
View all 19 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details
Completed

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)

NCT05155293

Conditions
Eye Diseases, Eye Diseases, Hereditary, Macular Degeneration, +3 more
Locations
  • Nemocnicni lekarna Sokolov Sokolov, Czechia
  • JSC Evex Medical Corporation Tbilisi, Georgia
  • Keneikai Hayashi Eye Hospital Fukuoka, Japan
  • Riga East University Hospital Clinical Centre "Bikernieki" Riga, Latvia
View Trial Details

Related conditions